重症+核药连获里程碑进展远大医药获中金上调目标价,全球首个零辐射核药基地投产在即

动脉网
May 08, 2025

远大医药全球创新药物和核药取得重要进展,中金上调其目标价。公司多项研发成果获资本市场认可,股价大涨。其脓毒症治疗药物和核药抗肿瘤产品有望成新增长点,带动公司业绩持续增长。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10